Boca Raton, FL -- (SBWIRE) -- 09/20/2013 -- StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners.StockFreak focuses on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks –ISIS Pharmaceuticals, Inc.(NASDAQ:ISIS), Frontline Ltd.(NYSE:FRO) ,GTx, Inc.(NASDAQ:GTXI),Fab Universal Corp(NYSEMKT:FU)
ISIS Pharmaceuticals, Inc.(NASDAQ:ISIS) reported the gain of 14.06% and closed at $36.27 with the total traded volume of 5.03 million shares. Its market capitalization is $4.18billion. The stock has a 52-week high price of $36.91and its 52-week low was recorded at $7.55
Isis Pharmaceuticals, Inc. develops therapeutic drugs inhibiting cell protein synthesis. The Company's principal activity is to develop and market RNA(RiboNucleicAcid)-based novel drugs to treat important diseases such as cardiovascular diseases, diabetes and asthma
What AUQ Charts Are Signaling for Traders? Find Out Here
Frontline Ltd.(NYSE:FRO) gained 16.98% and ended at $3.10.The total traded volume was 5.01 million shares and market capitalization arrived at $243.39 million. The stock has a 52-week high price of $4.12and its 52-week low was recorded at $1.71, while during last trade its minimum price was $2.53 and it gained the highest price of $3.12.
Frontline Ltd. is a Bermuda-based shipping company engaged primarily in the ownership and operation of oil tanker. The Company operates oil tankers of two sizes: Very Large Crude Carriers (VLCCs), which are between 200,000 and 320,000 deadweight tonnages (dwt), and Suezmax tankers, which are vessels between 120,000 and 170,000 dwt.
Is FRO Buy After The Recent Price Movement? Find Out Here
GTx, Inc.(NASDAQ:GTXI)’s reported gain 17.37% and close at $2.23 with the overall traded volume of 3.81 shares. Its market capitalization on last close reached to $140.90 million. The company has the total of 63.19M outstanding shares. Its intraday-low price was $1.91and its hit its day's highest price at $2.27.
GTx, Inc. is a biopharmaceutical company. The Company is developing selective androgen receptor modulators (SARMs) , a drugs with the potential to prevents and treat muscle wasting in patients with cancer and other musculoskeletal wasting or muscle loss conditions, including chronic sarcopenia (age related muscle loss).
Should GTXI a Buy or Sell Now? Find Out Here
Fab Universal Corp(NYSEMKT:FU) increase 24.20% settle at $8.93. Its total traded volume during last trading session was 3.52 million shares. The overall market worth of this company is about $185.80 million. The 52 week range of the stock remained $2.25 - $8.98, while its day's lowest price was $7.22 and its hit its day's highest price at $8.98.
FAB Universal Corp.(FAB), formerly Wizzard Software Corporation operates in two segments: Software and Media Services. The Software segment engages primarily in the development, sale, and service of custom and packaged computer software products.
What FU Charts Are Signaling for Traders? Find Out Here
StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. We strive to provide you with only the most opportunistic picks by pouring over mountains of data and charts. How often we send out our alerts is dependent on how often we find something worthwhile.
GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY THE FOLLOWING NOTICE AND DISCLAIMER MUST BE READ AND UNDERSTOOD AND YOU MUST AGREE TO THE TERMS CONTAINED THEREIN BEFORE USING THIS WEBSITE OR SUBSCRIBING TO OUR NEWSLETTER.
We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of StockFreak.com nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on StockFreak.com. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. StockFreak.com makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website.
StockFreak.com has been retained by an unrelated third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing on this website and in exchange for such services has received cash compensation from such third party. Questions regarding this website may be sent to info@StockFreak.com.
Read Our Disclaimer at: http://www.stockfreak.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)